9:00 AM

Keynote Address: RCTS, Real-World Data and the Patent Wars: Lies, Damn Lies, and Biostatistics Case Study presented by Dr. Stephen Ogenstad, Statogen Consulting

10:15 AM

Leveraging Baseline Covariate Adjustment Methods in Oncology Time-to-Event Studies presented by Dr. Daniel Backenroth, Johnson & Johnson

11:00 AM

Driving Operational Excellence: The Power of Statistical Innovation in Clinical Development presented by Dr. Fei Chen, Johnson & Johnson

12:45 PM

Bile Acids Are the Strong Indicators for the Progression of Metabolic Dysfunction Associated Steatotic Liver Disease in Ethnically Diverse Populations presented by Dr. Ekaterina Smirnova, Virginia Commonwealth University

1:45 PM

Integrated Analysis of Pre-Marketing Safety Data, Statistical Considerations and Estimands (part I) presented by Dr. Katarina Hedman, AstraZeneca

3:00 PM

Integrated Analysis of Pre-Marketing Safety Data, Statistical Considerations and Estimands (part II) presented by Dr. George Kordzakhia, AstraZeneca